VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

Pauline Lemmens  1     João Sabino  1     Edouard Louis  2     Wouter Van Moerkercke  3     Lieven Pouillon  4     Michaël Somers  5     Harald Peeters  6     Stijn Dr. Vanden Branden  7     Julie Busschaert  8     Filip Baert  9     Anneline Cremer  10     Philippe Potvin  11     Sophie Dewit  12     Arnaud Colard  13     Jo Swinnen  14     Guy Lambrecht  15     Christophe Claessens  16     Barbara Willandt  17     Pieter Dewint  17     Evi Van Dyck  18     Severine Vermeire  19     Marc Ferrante  19    
1 University Hospital Leuven, Leuven, Belgium
2 CHU Liège and Liège University, Liège, Belgium
3 AZ Groeninge, Kortrijk, Belgium
4 Imelda Hospital, Bonheiden, Belgium
5 University Hospital Antwerp, Antwerp, Belgium
6 University Hospital Gent, Gent, Belgium
7 Onze Lieve Vrouw Hospital, Aalst, Belgium
8 AZ Sint Lucas, Brugge, Belgium
9 AZ Delta, Roeselare, Belgium
10 Erasme University Hospital, Brussels, Belgium
11 AZ Rivierenland, Bornem, Belgium
12 Noorderhart Maria Hospital, Pelt, Belgium
13 Centre Hospitalier Chrétien - Clinique St Joseph, Liège, Belgium
14 Sint Franciscus Hospital, Heusden-Zolder, Belgium
15 AZ Damiaan, Oostende, Belgium
16 AZ Turnhout, Turnhout, Belgium
17 AZ Sint Jan, Brugge, Belgium
18 AZ Klina, Brasschaat, Belgium
19 Catholic University Leuven, Leuven, Belgium

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing